Quantitative Muscle Ultrasound: A Non‐Invasive Biomarker for Monitoring Duchenne Muscular Dystrophy
Muscle & Nerve · 2025
DOI: 10.1002/mus.28469 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Muscle & Nerve, 2025. Verfasst von Yu Jin Im und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical and Rehabilitation Medicine, Samsung Medical Center, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Muscle, Skeletal, Muscular Dystrophy, Duchenne. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: ENCell Co. Ltd., Republic of Korea.
Abstract (Originalsprache)
Introduction/Aims Quantitative muscle ultrasound (QMUS) shows promise as a non‐invasive biomarker for monitoring functional status in Duchenne muscular dystrophy (DMD). We evaluated the correlation between QMUS in various muscles and functional capacity assessments. Additionally, we compared the utility of composite QMUS scores as a comprehensive measure of disease progression to that of single‐muscle analyses.
Methods
We analyzed baseline data from an ongoing prospective study involving 23 patients with DMD (aged 5–18 years; mean 10.7; SD 4.2). High‐resolution ultrasound scans of muscle groups across the upper and lower limbs, head and neck, and diaphragm were assessed for muscle echogenicity using mean grayscale values (MGV). Functional capacity assessments included the 6‐min walk test (6MWT), North Star Ambulatory Assessment (NSAA), Performance of Upper Limb (PUL) module, timed function tests, quantitative muscle strength tests, and respiratory muscle strength tests.
Results
The composite MGV for upper and lower limbs demonstrated moderate to strong negative correlations with the 6MWT and NSAA scores (correlation coefficient [CC]: −0.44 to −0.74; p < 0.01) and strong to very strong positive correlations with rise‐from‐floor, 4‐stair climb, and 10‐m walk/run times (CC: 0.65 to 0.87; p < 0.01). For upper limb function, the MGV of the flexor carpi radialis muscle was negatively correlated with PUL scores (CC = −0.35, p = 0.02). However, no significant correlations were observed between QMUS parameters and muscle strength test ( p > 0.05).
Discussion
QMUS offers a non‐invasive method for assessing muscle changes and tracking disease progression in DMD. Trial Registration: ClinicalTrials.gov identifier: NCT05249361
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physical and Rehabilitation Medicine, Samsung Medical Center, Seoul, Republic of Korea.
- Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
- Department of Pediatrics, Samsung Medical Center, Seoul, Republic of Korea.
ORCID-Profile: Yu Jin Im, Yumi Choe, Jiwon Lee, Jeehun Lee, Jong Geol Do, Jeong-Yi Kwon
Förderung
- ENCell Co. Ltd., Republic of Korea
Zitieren
APA
Im, Y. J., Choe, Y., Lee, J., Lee, J., Do, J. G., & Kwon, J. Y. (2025). Quantitative Muscle Ultrasound: A Non‐Invasive Biomarker for Monitoring Duchenne Muscular Dystrophy. Muscle & Nerve. https://doi.org/10.1002/mus.28469
Vancouver
Im YJ, Choe Y, Lee J, Lee J, Do JG, Kwon JY. Quantitative Muscle Ultrasound: A Non‐Invasive Biomarker for Monitoring Duchenne Muscular Dystrophy. Muscle & Nerve. 2025. doi:10.1002/mus.28469
BibTeX
@article{Im2025,
author = {Im, Yu Jin and Choe, Yumi and Lee, Jiwon and Lee, Jeehun and Do, Jong Geol and Kwon, Jeong-Yi},
title = {Quantitative Muscle Ultrasound: A Non‐Invasive Biomarker for Monitoring Duchenne Muscular Dystrophy},
journal = {Muscle & Nerve},
year = {2025},
doi = {10.1002/mus.28469}
}
EUVIMED